Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic (Q33546865)

27 July 2017

1 reference

title

Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic (English)

1 reference

27 July 2017

0 references

1 reference

Williams NA

1

1 reference

PubMed ID

10098329

27 July 2017

Hirst TR

series ordinal

2

1 reference

PubMed ID

10098329

27 July 2017

Nashar TO

series ordinal

3

1 reference

27 July 2017

1 February 1999

1 reference

27 July 2017

1 reference

27 July 2017

20

1 reference

27 July 2017

2

1 reference

27 July 2017

95-101

1 reference

Structure of partially-activated E. coli heat-labile enterotoxin (LT) at 2.6 A resolution

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Kinetics of acid-mediated disassembly of the B subunit pentamer of Escherichia coli heat-labile enterotoxin. Molecular basis of pH stability.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Cholera toxin binding affinity and specificity for gangliosides determined by surface plasmon resonance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Adjuvant Effect of Cholera Enterotoxin on the Immune Response of the Mouse to Sheep Red Blood Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Whole cholera toxin and B subunit act synergistically as an adjuvant for the mucosal immune response of mice to keyhole limpet haemocyanin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Thein vitro production of cytokines by mucosal lymphocytes immunized by oral administration of keyhole limpet hemocyanin using cholera toxin as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Impaired mucosal immune responses in interleukin 4-targeted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Adjuvant activity of Escherichia coli heat-labile enterotoxin and effect on the induction of oral tolerance in mice to unrelated protein antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Escherichia coli heat-labile enterotoxin B subunits supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Immunoregulatory role of H-2 and intra-H-2 alleles on antibody responses to recombinant preparations of B-subunits of Escherichia coli heat-labile enterotoxin (rEtxB) and cholera toxin (rCtxB).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Induction of mucosal immunity against herpes simplex virus type 1 in the mouse protects against ocular infection and establishment of latency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Prevention of autoimmune disease due to lymphocyte modulation by the B-subunit of Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Structural studies of receptor binding by cholera toxin mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Cross-linking of cell surface ganglioside GM1 induces the selective apoptosis of mature CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction up-regulates MHC class II, B7, CD40, CD25 and ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Targeting autoantigen to B cells prevents the induction of a cell-mediated autoimmune disease in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Enhancement of the immune response to non-replicating herpes simplex virus type-1 preparations by mucosal administration in the presence of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Salivary, nasal, genital, and systemic antibody responses in monkeys immunized intranasally with a bacterial protein antigen and the Cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B subunit, and effects of pre-existing anti-CT immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Persistence of serum and salivary antibody responses after oral immunization with a bacterial protein antigen genetically linked to the A2/B subunits of cholera toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

Oral immunization with the saliva-binding region of Streptococcus mutans AgI/II genetically coupled to the cholera toxin B subunit elicits T-helper-cell responses in gut-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2898%2901397-8

7 January 2021

10.1016/S0167-5699(98)01397-8

Identifiers

DOI

1 reference

27 July 2017

1 reference

PubMed ID

10098329